CRISPR Therapeutics AG (CRSP) Net Margin Growth (5y) (2021 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Net Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - |
| 3 | Iovance Biotherapeutics | 3.80 Bn | 3.50 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.04 Bn | 3.04 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.64 Bn | 2.64 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.98 Bn | 1.82 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -98,002.00 |
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 5.05 Mn |
| Jun 30, 2025 | 15.77 Mn |
| Mar 31, 2025 | 2.87 Mn |
| Dec 31, 2024 | -26,104.00 |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -756,161.00 |
| Mar 31, 2024 | -837,003.00 |
| Dec 31, 2023 | 4.14 Mn |
| Jun 30, 2023 | 341,688.00 |
| Mar 31, 2023 | 203,088.00 |
| Dec 31, 2022 | -188.10 Mn |
| Sep 30, 2022 | -18.46 Mn |
| Jun 30, 2022 | -11.70 Mn |
| Mar 31, 2022 | -1.83 Mn |
| Dec 31, 2021 | -181,862.00 |
| Sep 30, 2021 | -1.45 Mn |
| Jun 30, 2021 | 224,329.00 |